Ipsen: all 356 studies

Page 1 of 4. Open to participants first (23), then studies with results posted, then the rest; newest registration first within each.

• A Study to Assess the Effectiveness and Safety of IPN10200 in Adult Chinese Participants With Moderate to Severe Wrinkle-like Lines Between the EyebrowsRecruitingNCT07779252Phase 3
• A Study to Assess How Well the Study Medicine IPN60340 Works in Combination With Azacitidine and Venetoclax, Compared to Placebo in Combination With Azacitidine and Venetoclax, in Participants With Newly Diagnosed Acute Myeloid Leukemia Who Cannot Receive Intensive ChemotherapyNot yet recruitingNCT07623187Phase 2/3
• A Study of the Effectiveness, Safety and the Long-term Outcomes of Participants With Progressive Familial Intrahepatic Cholestasis (PFIC) Who Take Odevixibat (Bylvay) in ChinaRecruitingNCT07588880
• A Study to Observe the Long-term Safety of Odevixibat in Patients With Alagille Syndrome (ALGS) Who Are Receiving Ongoing TreatmentRecruitingNCT07585097
• Elafibranor Pregnancy Surveillance Program: A Study to Evaluate the Safety of Elafibranor During PregnancyRecruitingNCT07556913
• A Study to Assess How Well and Safely Elafibranor Works in Adult Participants With Primary Sclerosing CholangitisRecruitingNCT07387549Phase 3
• Study of Cabozantinib in Participants With Neuroendocrine Tumors Who Have Already Received Prior TreatmentRecruitingNCT07314164
• A Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, Immunogenicity and Anti-tumour Activity of IPN01203 in Adults With Locally Advanced or Metastatic Solid Tumours Exposed to Immune Checkpoint Inhibitor TherapiesRecruitingNCT07213830Phase 1/2
• A Study to Assess the Safety, Tolerability, Pharmacokinetic, Pharmacodynamic, Immunogenicity and Antitumour Activity of IPN60300 in Adults With Locally Advanced or Metastatic Solid TumoursRecruitingNCT07213817Phase 1/2
• A Study of the Effectiveness, Safety and the Long-term Outcomes of Participants With Progressive Familial Intrahepatic Cholestasis (PFIC) Who Take Odevixibat (Bylvay) in South KoreaRecruitingNCT07185919
• A Study of IPN10200 for the Treatment of Cervical Dystonia in AdultsRecruitingNCT06937931Phase 2
• A Study Observing the Long-term, Effectiveness and Safety of Odevixibat (Bylvay) in Patients With Alagille Syndrome (ALGS) Who Are Receiving Ongoing TreatmentRecruitingNCT06850038
• Study of Navtemadlin add-on to Ruxolitinib in JAK Inhibitor-Naïve Patients With Myelofibrosis Who Have a Suboptimal Response to RuxolitinibRecruitingNCT06479135Phase 3
• Odevixibat Pregnancy and Lactation Surveillance Program: A Study to Evaluate the Safety of Odevixibat During Pregnancy and/or LactationRecruitingNCT06258902
• A Study to Document and to Further Describe Long-term Safety and Effectiveness of Palovarotene in Participants With Fibrodysplasia Ossificans Progressiva (FOP)RecruitingNCT06089616
• A Long-Term Study of Elafibranor in Adult Participants With Primary Biliary CholangitisRecruitingNCT06016842Phase 3
• Study of Navtemadlin as Maintenance Therapy in TP53WT Advanced or Recurrent Endometrial CancerRecruitingNCT05797831Phase 2/3
• Study of KRT-232 or TL-895 in Janus Associated Kinase Inhibitor Treatment-Naïve MyelofibrosisRecruitingNCT04878003Phase 2
• KRT-232 and TKI Study in Chronic Myeloid LeukemiaRecruitingNCT04835584Phase 1/2
• A Study to Assess the Safety and Efficacy of IPN10200 in Adult Participants With Upper Limb Spasticity.RecruitingNCT04752774Phase 1/2
• KRT-232 in Combination With TL-895 for the Treatment of R/R MF and KRT-232 for the Treatment of JAKi Intolerant MFRecruitingNCT04640532Phase 1/2
• Navtemadlin (KRT-232) With or Without Anti-PD-1/Anti-PD-L1 for the Treatment of Patients With Merkel Cell CarcinomaRecruitingNCT03787602Phase 1/2
• KRT-232 Versus Best Available Therapy for the Treatment of Subjects With Myelofibrosis Who Are Relapsed or Refractory to JAK Inhibitor TreatmentRecruitingNCT03662126Phase 2/3
• Safety and Tolerability of A3907 in Primary Sclerosing CholangitisTerminatedNCT05642468Phase 2Results posted
• Effects of Triptorelin Pamoate 6-month When Given to Adult Chinese Participants With Advanced Cancer in the ProstateCompletedNCT05590793Phase 3Results posted
• Effects of Triptorelin When Given Every 6-months Under the Skin to Adult Males With Cancer in the ProstateCompletedNCT05458856Phase 3Results posted
• A Study of the Safety, Tolerability and Effectiveness of EZM0414 (IPN60210) Investigative Product in Participants With Relapsed/Refractory Multiple Myeloma and Relapsed/Refractory Diffuse Large B Cell LymphomaTerminatedNCT05121103Phase 1Results posted
• A Study to Assess the Efficacy and Safety of the Triptorelin 6-month Formulation in Paediatric Participants With Central Precocious Puberty.CompletedNCT05029622Phase 3Results posted
• A Rollover Study to Further Evaluate the Safety and Efficacy of Palovarotene Capsules in Male and Female Participants Aged ≥14 Years With Fibrodysplasia Ossificans Progressiva (FOP) Who Have Completed the Relevant Parent Studies.CompletedNCT05027802Phase 3Results posted
• A Comparative Study to Evaluate the Effects and Mechanism of Action of Dysport®, Botox® and Xeomin® in the Extensor Digitorum Brevis Model in Healthy Adult Male ParticipantsCompletedNCT04970407Phase 1Results posted
• A Study to Compare the Safety and Efficacy of Dysport® and Botox® in Adults With Upper Limb Spasticity.CompletedNCT04936542Phase 4Results posted
• Study to Assess the Efficacy and Safety of Lanreotide Autogel® in Chinese Participants With GEP-NETsCompletedNCT04852679Phase 3Results posted
• SYMPHONY-2, A Trial to Examine Combination of Tazemetostat With Rituximab in Subjects With Relapsed/Refractory Follicular LymphomaTerminatedNCT04762160Phase 2Results posted
• Efficacy and Safety Study of Triptorelin 3-Month Formulation in Chinese Children With Central Precocious Puberty.CompletedNCT04736602Phase 3Results posted
• Efficacy and Safety of Odevixibat in Patients With Alagille SyndromeCompletedNCT04674761Phase 3Results posted
• Effects of Itraconazole and Rifampin on the Blood Tazemetostat LevelsCompletedNCT04537715Phase 1Results posted
• Study of Elafibranor in Patients With Primary Biliary Cholangitis (PBC)Active, not recruitingNCT04526665Phase 3Results posted
• A Study of Tazemetostat With Enzalutamide or Abiraterone/Prednisone in Participants With Advanced Prostate CancerTerminatedNCT04179864Phase 1/2Results posted
• A Study to Assess the Effectiveness and Safety of Irinotecan Liposome Injection, 5-fluorouracil/Leucovorin Plus Oxaliplatin in Patients Not Previously Treated for Metastatic Pancreatic Cancer, Compared to Nab-paclitaxel+Gemcitabine TreatmentCompletedNCT04083235Phase 3Results posted
• A Phase 2 Study of Elobixibat in Adults With NAFLD or NASHCompletedNCT04006145Phase 2Results posted
• Study of Cabozantinib as 2nd Line Treatment in Subjects With Locally Advanced or Metastatic Renal Cell Carcinoma (RCC) With a Clear-Cell Component Who Progressed After 1st Line Treatment With Checkpoint InhibitorsCompletedNCT03945773Phase 2Results posted
• Dose Escalation and Dose Expansion Study of IPN60090 in Patients With Advanced Solid TumoursTerminatedNCT03894540Phase 1Results posted
• Evaluate the Safety, Tolerability, Biodistribution and Anti Tumour Activity of 177LU-OPS201 With Companion Imaging 68Ga-OPS202 PET/CT in Previously Treated Subjects With Locally Advanced or Metastatic Cancers Expressing Somatostatin Receptor 2 (SSTR2)TerminatedNCT03773133Phase 1/2Results posted
• Define the Optimal Uptake Time of 68Ga-OPS202 When Used as a PET (Positron Emission Tomography) Imaging Agent in Subjects With Newly Diagnosed Breast CancerTerminatedNCT03697551Phase 2Results posted
• Dysport in Post-Surgical NeuralgiaCompletedNCT03663101Phase 2Results posted
• Long Term Safety & Efficacy Study Evaluating The Effect of A4250 in Children With PFICCompletedNCT03659916Phase 3Results posted
• Dysport in Vulvodynia Phase II StudyTerminatedNCT03598777Phase 2Results posted
• Dysport in Hallux Abducto Valgus (HAV) Phase IIaCompletedNCT03569098Phase 2Results posted
• This Study Will Investigate the Efficacy and Safety of A4250 in Children With PFIC Types 1 or 2CompletedNCT03566238Phase 3Results posted
• Study to Evaluate the Safety and Activity (Including Distribution) of 177Lu-3BP-227 in Subjects With Solid Tumours Expressing Neurotensin Receptor Type 1.TerminatedNCT03525392Phase 1Results posted
• An Efficacy and Safety Study of Palovarotene for the Treatment of MOTerminatedNCT03442985Phase 2Results posted
• Study to Compare a Dose of Telotristat Etiprate in Subjects With Renal Impairment With Matched Subjects With Normal Renal FunctionCompletedNCT03442725Phase 1Results posted
• An Efficacy and Safety Study of Palovarotene for the Treatment of Fibrodysplasia Ossificans Progressiva.CompletedNCT03312634Phase 3Results posted
• Study to Compare the Oestradiol Suppression, Clinical Efficacy and Safety of Two Formulations of Triptorelin (Triptorelin Pamoate PR 3-month and Triptorelin Acetate PR 1-month) in Chinese Subjects With EndometriosisCompletedNCT03232281Phase 3Results posted
• To Evaluate the Optimal Dose of 68Ga-OPS202 as a PET (Positron Emission Tomography) Imaging Agent in Subjects With Gastroenteropancreatic Neuroendocrine Tumour (GEP-NET)CompletedNCT03220217Phase 2Results posted
• Study of Irinotecan Liposome Injection (ONIVYDE®) in Patients With Small Cell Lung CancerCompletedNCT03088813Phase 3Results posted
• Chronic Administration of Diosmectite (SMECTA®) in Subjects With Chronic DiarrhoeaCompletedNCT03045926Phase 1Results posted
• Assessment of BIM23B065, Given as Repeated Subcutaneous Injection in Subjects With AcromegalyTerminatedNCT03045302Phase 2Results posted
• Open-Label, Multicenter, Two-Part, Phase 1 Study to Characterize Effects of a Moderate CYP3A Inhibitor on PK of Tazemetostat, Effects of Tazemetostat on PK of CYP2C8 and CYP2C19 Substrates, and Effect of Increased Gastric pH on PK of Tazemetostat in B-cell Lymphoma or Advanced Solid Tumor PatientsCompletedNCT03028103Phase 1Results posted
• Efficacy, Safety and Tolerability of Eziclen®/Izinova® Versus Klean-prep® on Bowel Cleansing in Adolescents Undergoing ColonoscopyCompletedNCT03008460Phase 3Results posted
• Study to Evaluate Effects of DYSPORT® Injected in Lower and Upper Limb Combined With Guided Self-Rehabilitation Contract (GSC)CompletedNCT02969356Phase 4Results posted
• Study of the EZH2 Inhibitor Tazemetostat in Malignant MesotheliomaCompletedNCT02860286Phase 2Results posted
• Efficacy of Diosmectite (Smecta®) in the Symptomatic Treatment of Acute Diarrhoea in AdultsCompletedNCT02704091Phase 4Results posted
• Efficacy and Safety of Lanreotide Autogel (ATG) in Combination With Temozolomide in Subjects With Thoracic Neuroendocrine Tumors.CompletedNCT02698410Phase 2Results posted
• Efficacy and Safety of Lanreotide Autogel/ Depot 120 mg vs. Placebo in Subjects With Lung Neuroendocrine TumoursTerminatedNCT02683941Phase 3Results posted
• Study to Evaluate a Dose of Telotristat Etiprate in Male and Female With Mild, Moderate and Severe Hepatic Insufficiency and Matched Healthy SubjectsCompletedNCT02683577Phase 1Results posted
• Dysport® Treatment of Urinary Incontinence in Adults Subjects With Neurogenic Detrusor Overactivity (NDO) Due to Spinal Cord Injury or Multiple Sclerosis - Study 2TerminatedNCT02660359Phase 3Results posted
• Dysport® Treatment of Urinary Incontinence in Adults Subjects With Neurogenic Detrusor Overactivity (NDO) Due to Spinal Cord Injury or Multiple Sclerosis - Study 1TerminatedNCT02660138Phase 3Results posted
• Efficacy and Safety Study in Pancreatic or Midgut Neuroendocrine Tumours Having Progressed Radiologically While Previously Treated With Lanreotide Autogel® 120 mgCompletedNCT02651987Phase 2Results posted
• A Study of Tazemetostat in Adult Participants With Soft Tissue SarcomaCompletedNCT02601950Phase 2Results posted
• EZH2 Inhibitor Tazemetostat in Pediatric Subjects With Relapsed or Refractory INI1-Negative Tumors or Synovial SarcomaCompletedNCT02601937Phase 1Results posted
• Study to Evaluate the Safety and Preliminary Efficacy of 177Lu-OPS201 in NETsTerminatedNCT02592707Phase 1/2Results posted
• Study of Nanoliposomal Irinotecan (Nal-IRI)-Containing Regimens Versus Nab-paclitaxel Plus Gemcitabine in Patients With Previously Untreated, Metastatic Pancreatic AdenocarcinomaCompletedNCT02551991Phase 2Results posted
• In-Home Evaluation of Episodic Administration of Palovarotene in Fibrodysplasia Ossificans Progressiva (FOP) SubjectsTerminatedNCT02521792Phase 2Results posted
• Efficacy and Safety of Botulinum Toxin Type A Haemagglutinin Complex Next Generation (BTX-A-HAC NG) in Glabellar LinesCompletedNCT02493946Phase 3Results posted
• Efficacy and Safety of Lanreotide Autogel® 60, 90 or 120 mg With Lanreotide 40 mg Prolonged Release (PR) in AcromegalyCompletedNCT02493517Phase 3Results posted
• Dysport in the Treatment of Glabellar Lines in Chinese SubjectsCompletedNCT02450526Phase 3Results posted
• Study to Determine the Maximum Tolerated Dose, Safety and Tolerability of a Single Dose of Lanreotide Prolonged Release Formulation (PRF) in Subjects With AcromegalyCompletedNCT02396953Phase 1/2Results posted
• Quality of Life in Patients With Inoperable Malignant Bowel ObstructionTerminatedNCT02365584Phase 2Results posted
• Efficacy and Safety of Clostridium Botulinum Toxin Type A to Improve Appearance of Moderate to Severe Glabellar LinesCompletedNCT02353871Phase 3Results posted
• Efficacy, Safety and Tolerability of Eziclen in Adult Subjects Undergoing ColonoscopyCompletedNCT02321462Phase 3Results posted
• Study to Assess Impact of Dysport Injections Early After Stroke on Upper Limb Spasticity ProgressionCompletedNCT02321436Phase 4Results posted
• An Open-Label Extension Study of Palovarotene Treatment in Fibrodysplasia Ossificans Progressiva (FOP)CompletedNCT02279095Phase 2Results posted
• Study to Assess Efficacy and Safety of Lanreotide Autogel 120 MG in Treatment of Clinical Symptoms Associated With Inoperable Malignant Intestinal ObstructionCompletedNCT02275338Phase 2Results posted
• Combination of Lanreotide Autogel 120mg and Temozolomide in Progressive GEP-NETCompletedNCT02231762Phase 2Results posted
• Study Exploring Safety, Pharmacokinetic and Pharmacodynamic of BN82451 in Male Huntington's Disease PatientsTerminatedNCT02231580Phase 2Results posted
• An Efficacy and Safety Study of Palovarotene to Treat Preosseous Flare-ups in FOP SubjectsCompletedNCT02190747Phase 2Results posted
• 68Ga-OPS202 Study for Diagnostic Imaging of GEP NETCompletedNCT02162446Phase 1/2Results posted
• Efficacy And Safety Of Dysport In The Treatment Of Upper Limb Spasticity In ChildrenCompletedNCT02106351Phase 3Results posted
• Circulating Tumour Cells in Somatuline Autogel Treated NeuroEndocrine Tumours PatientsCompletedNCT02075606Phase 4Results posted
• Study Of Tasquinimod In Asian Chemo-Naïve Patients With Metastatic Castrate-Resistant Prostate CancerTerminatedNCT02057666Phase 3Results posted
• Programme of Acromegaly Screening in Patients With Associated Somatic DisordersCompletedNCT02020967Results posted
• Study of Tazemetostat as Single Agent in Solid Tumors or B-cell Lymphomas and in Combination With Prednisolone in DLBCLCompletedNCT01897571Phase 1/2Results posted
• MM-398 (Nanoliposomal Irinotecan, Nal-IRI) to Determine Tumor Drug Levels and to Evaluate the Feasibility of Ferumoxytol Magnetic Resonance Imaging to Measure Tumor Associated Macrophages and to Predict Patient Response to TreatmentCompletedNCT01770353Phase 1Results posted
• Long Term Safety And Effectiveness Of Dysport® In Adults With Cervical DystoniaCompletedNCT01753336Phase 3Results posted
• Efficacy and Safety of DYSPORT® Using 2mL Dilution in Adults With Cervical Dystonia.CompletedNCT01753310Phase 3Results posted
• A Study of Immediate 9 Months Adjuvant Hormone Therapy With Triptorelin 11.25 mg Versus Active Surveillance After Radical Prostatectomy in High Risk Prostate Cancer Patients.CompletedNCT01753297Phase 4Results posted
• A Study With Tasquinimod Treating Patients With Hepatocellular, Ovarian, Renal Cell and Gastric CancersCompletedNCT01743469Phase 2Results posted
• A Proof of Concept Study of Maintenance Therapy With Tasquinimod in Patients With Metastatic Castrate-resistant Prostate Cancer Who Are Not Progressing After a First Line Docetaxel Based ChemotherapyTerminatedNCT01732549Phase 2Results posted
• Induction and Maintenance of Castration After Subcutaneous Injections of Triptorelin Pamoate in Patients With Prostate CancerCompletedNCT01715129Phase 3Results posted

← Ipsen overview and focus areas